Julie Jordan Insider Profile

4 Followers
Julie Jordan, CMO at Q32 Bio, holds 7.50K shares in Q32 Bio (Ticker: QTTB), holds ― shares in Neurogene (Ticker: NGNE).
tipranks
Julie Jordan

Julie Jordan
Q32 Bio (QTTB)
CMO

Not Ranked
Julie Jordan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$327K
100.00%
0.00%
A breakdown of Julie Jordan's holdings

Insider Roles

Q32 Bio
(QTTB)
CMO
Neurogene
(NGNE)
Chief Medical Officer
Roles that Julie Jordan holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Julie Jordan

Julie Jordan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Q32 Bio
Aug 07, 2023
CMO
Uninformative Buy
6.57K
$327.43K
Neurogene
Chief Medical Officer
List of latest transactions for each holding click on a transaction to see Julie Jordan's performance on stock

Julie Jordan insider profile FAQ

What is the percentage of profitable transactions made by Julie Jordan?
The percentage of profitable transactions made by Julie Jordan is ―.
    What is the average return per transaction made by Julie Jordan?
    The average return per transaction made by Julie Jordan is ―.
      What stocks does Julie Jordan hold?
      Julie Jordan holds: QTTB, NGNE stocks.
        What was Julie Jordan’s latest transaction?
        Julie Jordan latest transaction was an Uninformative Buy of $6.57K.
          What was Julie Jordan's most profitable transaction?
          Julie Jordan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Julie Jordan's role in Q32 Bio?
            Julie Jordan's role in Q32 Bio is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.